<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23281444</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>07</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1525-0024</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title>
                <ISOAbbreviation>Mol. Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Regulating cytokine function enhances safety and activity of genetic cancer therapies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>167-74</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/mt.2012.225</ELocationID>
            <Abstract>
                <AbstractText>Genetic therapies, including transfected immune cells and viral vectors, continue to show clinical responses as systemically deliverable and targeted therapeutics, with the first such approaches having been approved for cancer treatment. The majority of these employ cytokine transgenes. However, expression of cytokines early after systemic delivery can result in increased toxicity and nonspecific induction of the immune response. In addition, premature immune-mediated clearance of the therapy may result, especially for viral-based approaches. Here, it was initially verified that cytokine (interleukin (IL)2) or chemokine (CCL5) expression from a systemically delivered oncolytic virus resulted in reduced oncolytic activity and suboptimal immune activation, while IL2 also resulted in increased toxicity. However, all these limitations could be overcome through incorporation of exogenous regulation of cytokine or chemokine transgene function through fusion of a small and externally controllable destabilizing domain to the protein of interest. Regulation allowed an initial phase without cytokine function, permitting enhanced delivery and oncolytic activity before activation of cytokine function and a subsequent phase of enhanced and tumor-targeted immunotherapeutic activity. As a result of this exogenous regulation of cytokine function, both oncolytic and immune-mediated mechanisms of action were optimized, greatly enhancing therapeutic activity, while toxicity was significantly reduced.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hannah</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sampath</LastName>
                    <ForeName>Padma</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>Weizhou</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thorne</LastName>
                    <ForeName>Stephen H</ForeName>
                    <Initials>SH</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P01 CA132714</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 CA047904</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 CA140215</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 CA047904-21S3</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2012</Year>
                <Month>11</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Ther</MedlineTA>
            <NlmUniqueID>100890581</NlmUniqueID>
            <ISSNLinking>1525-0016</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015316" MajorTopicYN="Y">Genetic Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050130" MajorTopicYN="N">Oncolytic Virotherapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014616" MajorTopicYN="N">Vaccinia virus</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23281444</ArticleId>
            <ArticleId IdType="pii">S1525-0016(16)30572-X</ArticleId>
            <ArticleId IdType="doi">10.1038/mt.2012.225</ArticleId>
            <ArticleId IdType="pmc">PMC3538315</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2006 Sep 8;126(5):995-1004</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16959577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2010 Jun;28(6):531-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20531312</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2008 Oct;14(10):1123-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18836461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2001 Jul;75(13):5958-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11390597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):91-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20223697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2006 Nov 15;12(22):6737-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17121894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Theranostics. 2012;2(4):363-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22509200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Surg Oncol. 2010 Mar;17(3):718-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19915919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2001 Dec 15;61(24):8751-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11751395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2011 Apr;19(4):627-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21455205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biotechniques. 1997 Dec;23(6):1094-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9421642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Gene Ther. 2010 Jan;21(1):51-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19715403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2007 Nov;117(11):3350-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17965776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2007 Aug 24;282(34):24866-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17603093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2009 Jul 2;460(7251):108-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19543266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncology (Williston Park). 2002 Nov;16(11 Suppl 13):4-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12469934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2011 Apr;29(4):295-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21478830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Biol. 1989 Dec 20;210(4):771-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2515287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chem Biol. 2006 Jan;13(1):11-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16426967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2008 May;28(5):710-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18468462</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Med. 2007 Dec;4(12):e353</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18162040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Gene Ther. 2009 Jan;16(1):33-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18670453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharmacol. 2001 Aug;41(8):870-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11504275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2011 Sep 1;477(7362):99-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21886163</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2008 Sep;16(9):1556-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18665158</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 2000 Mar 15;268(2):471-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10704355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2009 Oct 1;69(19):7713-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19773437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2008 Jun;9(6):533-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18495536</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>